CancerNetwork Members: Login | Register
CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Integrative Oncology

ONCOLOGY. Vol. 25 No. 10
INTEGRATIVE ONCOLOGY 

Ginkgo (Ginkgo biloba)

Complementary Therapies, Herbs, and Other OTC Agents

By Barrie Cassileth, PhD1 | September 12, 2011

ALSO KNOWN AS: Maidenhair tree, kew tree, bai guo, yin xing ye.

BACKGROUND: Ginkgo biloba, one of the oldest living tree species, is cultivated worldwide for its medicinal properties and aesthetic appeal. The leaves and seeds are used in traditional medicine to treat respiratory diseases, circulatory disorders, sexual dysfunction, and loss of hearing. The leaf extract is a popular herbal supplement and is promoted extensively for memory loss. Ginkgo is also used by many cancer patients to treat and prevent cancer, and to reduce chemotherapy-associated toxicity. Ginkgo supplements are available as tablets, capsules, and liquid extracts. The dried leaves are used for tea.

RESEARCH: In vitro studies of ginkgo extracts indicate anti-infective,[1] chemopreventive,[2] anticancer,[3] and cytotoxic[4] effects. Epidemiological data indicate that ginkgo may play a role in reducing the risk of ovarian cancer.[5] However, data from the Gingko Evaluation of Memory (GEM) study, in which cancer risk was the secondary outcome, do not support gingko's effectiveness in reducing cancer risk.[6] Studies in patients with gastric cancer showed reduction in tumor area following oral supplementation with capsules of ginkgo exocarp polysaccharides.[4] A combination of an injectable form of ginkgo extract and 5-fluorouracil improved the quality of life of patients with advanced colorectal cancer.[7] Further studies are needed to determine the anticancer potential of ginkgo supplements.

TAKE HOME POINTS
• Evidence of an anticancer effect for ginkgo is limited.
• Ginkgo use is associated with adverse effects and it also may interact with prescription medications, such as anticoagulants.
• Data regarding gingko's ability to prevent dementia or Alzheimer disease are conflicting.

For additional information, visit the Memorial Sloan-Kettering Cancer Center Integrative Medicine Service website, "About Herbs," at http://www.mskcc.org/AboutHerbs.

ADVERSE REACTIONS:Seizures were reported in patients predisposed to seizures or on medications that lower the seizure threshold (eg, prochlorperazine(Drug information on prochlorperazine), chlorpromazine(Drug information on chlorpromazine), perphenazine(Drug information on perphenazine)).[8] Spontaneous bleeding has also been reported.[9,10] Increased viral load was observed in a 47-year-old HIV-infected patient who used gingko along with antiretroviral therapy.[11]

HERB-DRUG INTERACTIONS: When used with NSAIDs, ginkgo may have additive anticoagulant/antiplatelet effects.[12] Ginkgo may cause seizures when combined with medications that lower the seizure threshold.[8] Ginkgo can alter insulin secretion and affect blood glucose levels.[13] Studies show that ginkgo can inhibit and induce the CYP450 1A2, 2D6, and 3A4 enzymes,[14,15] affecting the levels of drugs that are metabolized by these enzymes. Ginkgo inhibits P-glycoprotein and therefore may interfere with drugs that are transported by P-glycoprotein.[16]

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
RELATED CONTENT

The Key to Reducing Quackery Lies in Healing Patients and Treating Their Experience
ONCOLOGY,  August 20, 2012
Quackery, Placebos, and Other Thoughts: An Integrative Oncologist’s Perspective
ONCOLOGY,  August 20, 2012
Cancer Quackery: The Persistent Popularity of Useless, Irrational 'Alternative' Treatments
ONCOLOGY,  August 20, 2012
Integrative Medicine: Not Just Garnish
ONCOLOGY Nurse Edition,  May 9, 2012
Green Tea (Camellia sinensis)
ONCOLOGY,  December 31, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Skin Lesions
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Integrative Oncology
Evidence on Integrative Oncology
Guidelines on Integrative Oncology
Patient Education on Integrative Oncology
Clinical Trials on Integrative Oncology
Practical Articles on Integrative Oncology
Research and Reviews on Integrative Oncology
All "Integrative Oncology" results


CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy